메뉴 건너뛰기




Volumn 41, Issue 7, 2010, Pages 951-959

The close correlation between 8-hydroxy-2′-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer

Author keywords

8 OHdG; EGFR activating mutations; Gefitinib; NSCLC; YB 1

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; DNA GLYCOSYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; PEPTIDE NUCLEIC ACID; Y BOX BINDING PROTEIN 1;

EID: 77953287048     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.12.007     Document Type: Article
Times cited : (10)

References (35)
  • 1
    • 0035467993 scopus 로고    scopus 로고
    • Global cancer statistics in the year 2000
    • Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2 (2001) 533-543
    • (2001) Lancet Oncol , vol.2 , pp. 533-543
    • Parkin, D.M.1
  • 2
    • 33847276516 scopus 로고    scopus 로고
    • Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
    • Ohe Y., Ohashi Y., Kubota K., et al. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18 (2007) 317-323
    • (2007) Ann Oncol , vol.18 , pp. 317-323
    • Ohe, Y.1    Ohashi, Y.2    Kubota, K.3
  • 3
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3
  • 4
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
    • Paez J.G., Janne P.A., Lee J.C., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.G.1    Janne, P.A.2    Lee, J.C.3
  • 5
    • 4444344330 scopus 로고    scopus 로고
    • EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
    • Pao W., Miller V., Zakowski M., et al. EGF receptor gene mutations are common in lung cancer from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101 (2004) 13306-13311
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 13306-13311
    • Pao, W.1    Miller, V.2    Zakowski, M.3
  • 6
    • 33846202907 scopus 로고    scopus 로고
    • Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs
    • Ono M., and Kuwano M. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res 12 (2006) 7242-7251
    • (2006) Clin Cancer Res , vol.12 , pp. 7242-7251
    • Ono, M.1    Kuwano, M.2
  • 7
    • 20044364940 scopus 로고    scopus 로고
    • Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
    • Shigematsu H., Lin L., Takahashi T., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 (2005) 339-346
    • (2005) J Natl Cancer Inst , vol.97 , pp. 339-346
    • Shigematsu, H.1    Lin, L.2    Takahashi, T.3
  • 8
    • 69949162760 scopus 로고    scopus 로고
    • Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
    • Mok T.S., Wu Y.L., Thongprasert S., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361 (2009) 947-957
    • (2009) N Engl J Med , vol.361 , pp. 947-957
    • Mok, T.S.1    Wu, Y.L.2    Thongprasert, S.3
  • 9
    • 4444339833 scopus 로고    scopus 로고
    • Oxidative DNA damage and disease: induction, repair and significance
    • Evans M.D., Dizdaroglu M., and Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567 (2004) 1-61
    • (2004) Mutat Res , vol.567 , pp. 1-61
    • Evans, M.D.1    Dizdaroglu, M.2    Cooke, M.S.3
  • 10
    • 34147174320 scopus 로고    scopus 로고
    • Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis
    • Tsuzuki T., Nakatsu Y., and Nakabeppu Y. Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis. Cancer Sci 98 (2007) 465-470
    • (2007) Cancer Sci , vol.98 , pp. 465-470
    • Tsuzuki, T.1    Nakatsu, Y.2    Nakabeppu, Y.3
  • 11
    • 38549153790 scopus 로고    scopus 로고
    • Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs
    • Oka S., Ohno M., Tsuchimoto D., Sakumi K., Furuichi M., and Nakabeppu Y. Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J 27 (2008) 421-432
    • (2008) EMBO J , vol.27 , pp. 421-432
    • Oka, S.1    Ohno, M.2    Tsuchimoto, D.3    Sakumi, K.4    Furuichi, M.5    Nakabeppu, Y.6
  • 12
    • 0037374556 scopus 로고    scopus 로고
    • Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption
    • Sakumi K., Tominaga Y., Furuichi M., et al. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res 63 (2003) 902-905
    • (2003) Cancer Res , vol.63 , pp. 902-905
    • Sakumi, K.1    Tominaga, Y.2    Furuichi, M.3
  • 13
    • 3042739635 scopus 로고    scopus 로고
    • Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases
    • Russo M.T., De Luca G., Degan P., et al. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res 64 (2004) 4411-4414
    • (2004) Cancer Res , vol.64 , pp. 4411-4414
    • Russo, M.T.1    De Luca, G.2    Degan, P.3
  • 14
    • 0032508052 scopus 로고    scopus 로고
    • Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours
    • Chevillard S., Radicella J.P., Levalois C., et al. Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene 16 (1998) 3083-3086
    • (1998) Oncogene , vol.16 , pp. 3083-3086
    • Chevillard, S.1    Radicella, J.P.2    Levalois, C.3
  • 15
    • 27744531188 scopus 로고    scopus 로고
    • Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review
    • Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162 (2005) 925-942
    • (2005) Am J Epidemiol , vol.162 , pp. 925-942
    • Hung, R.J.1    Hall, J.2    Brennan, P.3    Boffetta, P.4
  • 16
    • 12444255113 scopus 로고    scopus 로고
    • Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers
    • Chiou C.C., Chang P.Y., Chan E.C., Wu T.L., Tsao K.C., and Wu J.T. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta 334 (2003) 87-94
    • (2003) Clin Chim Acta , vol.334 , pp. 87-94
    • Chiou, C.C.1    Chang, P.Y.2    Chan, E.C.3    Wu, T.L.4    Tsao, K.C.5    Wu, J.T.6
  • 17
    • 34548292501 scopus 로고    scopus 로고
    • Base excision repair modulation as a risk factor for human cancers
    • Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med 28 (2007) 258-275
    • (2007) Mol Aspects Med , vol.28 , pp. 258-275
    • Tudek, B.1
  • 18
    • 33749317535 scopus 로고    scopus 로고
    • 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures
    • Pilger A., and Rüdiger H.W. 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health 80 (2006) 1-15
    • (2006) Int Arch Occup Environ Health , vol.80 , pp. 1-15
    • Pilger, A.1    Rüdiger, H.W.2
  • 19
    • 61749096817 scopus 로고    scopus 로고
    • Biomarkers of oxidative stress and damage in human populations exposed to arsenic
    • De Vizcaya-Ruiz A., Barbier O., Ruiz-Ramos R., and Cebrian M.E. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 674 (2009) 85-92
    • (2009) Mutat Res , vol.674 , pp. 85-92
    • De Vizcaya-Ruiz, A.1    Barbier, O.2    Ruiz-Ramos, R.3    Cebrian, M.E.4
  • 20
    • 0032147094 scopus 로고    scopus 로고
    • Gene regulation by Y-box proteins: coupling control of transcription and translation
    • Matsumoto K., and Wolffe A.P. Gene regulation by Y-box proteins: coupling control of transcription and translation. Trends Cell Biol 8 (1998) 318-323
    • (1998) Trends Cell Biol , vol.8 , pp. 318-323
    • Matsumoto, K.1    Wolffe, A.P.2
  • 21
    • 0037829212 scopus 로고    scopus 로고
    • The pleiotropic functions of the Y-box-binding protein, YB-1
    • Kohno K., Izumi H., Uchiumi T., et al. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25 (2003) 691-698
    • (2003) Bioessays , vol.25 , pp. 691-698
    • Kohno, K.1    Izumi, H.2    Uchiumi, T.3
  • 22
    • 20144368814 scopus 로고    scopus 로고
    • YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification
    • Bergmann S., Royer-Pokara B., Fietze E., et al. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res 65 (2005) 4078-4087
    • (2005) Cancer Res , vol.65 , pp. 4078-4087
    • Bergmann, S.1    Royer-Pokara, B.2    Fietze, E.3
  • 23
    • 67349125744 scopus 로고    scopus 로고
    • Novel DNA mismatch-repair activity involving YB-1 in human mitochondria
    • de Souza-Pinto N., Mason P., Hashiguchi K., et al. Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair 8 (2009) 704-719
    • (2009) DNA Repair , vol.8 , pp. 704-719
    • de Souza-Pinto, N.1    Mason, P.2    Hashiguchi, K.3
  • 24
    • 0344820727 scopus 로고    scopus 로고
    • Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
    • Ise T., Nagatani G., Imamura T., et al. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res 59 (1999) 342-346
    • (1999) Cancer Res , vol.59 , pp. 342-346
    • Ise, T.1    Nagatani, G.2    Imamura, T.3
  • 25
    • 0037159257 scopus 로고    scopus 로고
    • Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine
    • Hayakawa H., Uchiumi T., Fukuda T., et al. Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine. Biochemistry 41 (2002) 12739-12744
    • (2002) Biochemistry , vol.41 , pp. 12739-12744
    • Hayakawa, H.1    Uchiumi, T.2    Fukuda, T.3
  • 26
    • 0034796873 scopus 로고    scopus 로고
    • Nuclear expression of the Y-box binding protein as a novel marker of disease progression in non-small cell lung cancer
    • Shibahara K., Sugio K., Osaki T., et al. Nuclear expression of the Y-box binding protein as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res 7 (2001) 3151-3155
    • (2001) Clin Cancer Res , vol.7 , pp. 3151-3155
    • Shibahara, K.1    Sugio, K.2    Osaki, T.3
  • 27
    • 69549091683 scopus 로고    scopus 로고
    • Nuclear Y-box binding protein-1 (YB-1), a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer
    • Kashihara M., Azuma K., Kawahara A., et al. Nuclear Y-box binding protein-1 (YB-1), a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J Thorac Oncol 4 (2009) 1066-1074
    • (2009) J Thorac Oncol , vol.4 , pp. 1066-1074
    • Kashihara, M.1    Azuma, K.2    Kawahara, A.3
  • 28
    • 33947502512 scopus 로고    scopus 로고
    • Lung cancer in never smokers: a review
    • Subramanian J., and Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 25 (2007) 561-570
    • (2007) J Clin Oncol , vol.25 , pp. 561-570
    • Subramanian, J.1    Govindan, R.2
  • 29
    • 38949169542 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma
    • Toyooka S., Takano T., Kosaka T., et al. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma. Cancer Sci 99 (2008) 303-308
    • (2008) Cancer Sci , vol.99 , pp. 303-308
    • Toyooka, S.1    Takano, T.2    Kosaka, T.3
  • 30
    • 0041438479 scopus 로고    scopus 로고
    • Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer
    • Gackowski D., Speina E., Zielinska M., et al. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res 63 (2003) 4899-4902
    • (2003) Cancer Res , vol.63 , pp. 4899-4902
    • Gackowski, D.1    Speina, E.2    Zielinska, M.3
  • 32
    • 0042090555 scopus 로고    scopus 로고
    • Decreased repair activities of 1, N6-ethenoadenine and 3, N4-ethenocytosine in lung adenocarcinoma patients
    • Speina E., Zielińska M., Barbin A., et al. Decreased repair activities of 1, N6-ethenoadenine and 3, N4-ethenocytosine in lung adenocarcinoma patients. Cancer Res 63 (2003) 4351-4357
    • (2003) Cancer Res , vol.63 , pp. 4351-4357
    • Speina, E.1    Zielińska, M.2    Barbin, A.3
  • 33
    • 9444259316 scopus 로고    scopus 로고
    • The role of nuclear Y-box binding protein 1 as a global marker in drug resistance
    • Kuwano M., Oda Y., Izumi H., et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol Cancer Ther 3 (2004) 1485-1492
    • (2004) Mol Cancer Ther , vol.3 , pp. 1485-1492
    • Kuwano, M.1    Oda, Y.2    Izumi, H.3
  • 34
    • 1242342944 scopus 로고    scopus 로고
    • YB-1 promotes separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins
    • Gaudreaut I., Guay D., and Lebel M. YB-1 promotes separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins. Nucleic Acids Res 32 (2004) 316-327
    • (2004) Nucleic Acids Res , vol.32 , pp. 316-327
    • Gaudreaut, I.1    Guay, D.2    Lebel, M.3
  • 35
    • 35348971904 scopus 로고    scopus 로고
    • Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress
    • Das S., Chattopadhyay R., Bhakat K.K., et al. Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress. J Biol Chem 282 (2007) 28474-28484
    • (2007) J Biol Chem , vol.282 , pp. 28474-28484
    • Das, S.1    Chattopadhyay, R.2    Bhakat, K.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.